| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4935086 | Schizophrenia Research | 2016 | 9 Pages |
Abstract
Taken together, these data suggest that aripiprazole may be therapeutic for schizophrenia by reducing microglial inflammatory reactions, and TRPM7 may be a novel therapeutic target for schizophrenia. Further studies are needed to validate these findings.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Mina Sato-Kasai, Takahiro A. ((Associate Professor)), Masahiro Ohgidani, Yoshito Mizoguchi, Noriaki Sagata, Shogo Inamine, Hideki Horikawa, Kohei Hayakawa, Norihiro Shimokawa, Sota Kyuragi, Yoshihiro Seki, Akira Monji, Shigenobu Kanba,